Ratio of preoperative atrial natriuretic peptide to brain natriuretic peptide predicts the outcome of the maze procedure in mitral valve disease
- PMID: 23448148
- PMCID: PMC3606469
- DOI: 10.1186/1749-8090-8-32
Ratio of preoperative atrial natriuretic peptide to brain natriuretic peptide predicts the outcome of the maze procedure in mitral valve disease
Abstract
Background: Although the maze procedure is an established surgical treatment for eliminating atrial fibrillation (AF), its efficacy in patients with mitral valve disease has remained unsatisfactory. A useful predictive marker for the outcome of the maze procedure is needed. The aim of this study was to investigate whether the preoperative ratio of atrial natriuretic peptide (ANP) to brain natriuretic peptide (BNP) reflects atrial fibrosis and can be used to predict the maze procedure outcome in patients with mitral valve disease.
Methods: A total of 23 consecutive patients who underwent the radial approach to the maze procedure combined with mitral valve surgery were included in this study and were divided into a sinus rhythm (SR) group (n=16) and an AF group (n=7) based on postoperative cardiac rhythm. Plasma samples were obtained at rest before the operation and were analysed for ANP and BNP levels. Atrial tissue samples taken during surgery were used to quantify interstitial fibrosis.
Results: The preoperative ANP-to-BNP ratio in the SR group was significantly higher than that in the AF group (0.74 +/- 0.29 vs. 0.42 +/- 0.28, respectively; p=0.025). Receiver operating characteristic (ROC) curve analysis was used to identify factors that predict outcomes after the maze procedure. The area under the ROC curve for the ANP-to-BNP ratio (0.81) was greater than for any other preoperative factors. Moreover, the preoperative ANP-to-BNP ratio demonstrated a negative correlation with left atrial fibrosis (r=-0.69; p=0.003).
Conclusions: The preoperative ANP-to-BNP ratio can predict maze procedure outcome in patients with mitral valve disease, and it represents a potential biomarker for left atrial fibrosis.
Figures




Similar articles
-
Decreased plasma brain natriuretic peptide levels after a successful maze procedure.J Heart Valve Dis. 2003 May;12(3):287-91. J Heart Valve Dis. 2003. PMID: 12803326
-
High recurrence of atrial fibrillation in patients with high tissue atrial natriuretic peptide and amyloid levels after concomitant maze and mitral valve surgery.J Cardiol. 2017 Jan;69(1):345-352. doi: 10.1016/j.jjcc.2016.07.012. Epub 2016 Aug 25. J Cardiol. 2017. PMID: 27567174
-
Plasma atrial natriuretic peptide concentration inversely correlates with left atrial collagen volume fraction in patients with atrial fibrillation: plasma ANP as a possible biochemical marker to predict the outcome of the maze procedure.J Am Coll Cardiol. 2002 Jan 16;39(2):288-94. doi: 10.1016/s0735-1097(01)01719-3. J Am Coll Cardiol. 2002. PMID: 11788221
-
Natriuretic peptides as predictors for atrial fibrillation recurrence after catheter ablation: A meta-analysis.Medicine (Baltimore). 2023 May 12;102(19):e33704. doi: 10.1097/MD.0000000000033704. Medicine (Baltimore). 2023. PMID: 37171306 Free PMC article.
-
Atrial Natriuretic Peptides as a Bridge between Atrial Fibrillation, Heart Failure, and Amyloidosis of the Atria.Int J Mol Sci. 2023 Mar 30;24(7):6470. doi: 10.3390/ijms24076470. Int J Mol Sci. 2023. PMID: 37047444 Free PMC article. Review.
Cited by
-
Direct comparison of prognostic ability of cardiac biomarkers for cardiogenic stroke and clinical outcome in patients with stroke.Heart Vessels. 2019 Jul;34(7):1178-1186. doi: 10.1007/s00380-019-01345-w. Epub 2019 Jan 17. Heart Vessels. 2019. PMID: 30656414
-
Impact of epicardial ablation of concomitant atrial fibrillation on atrial natriuretic peptide levels and atrial function in 6 months follow-up: does preoperative ANP level predict outcome of ablation?J Cardiothorac Surg. 2013 Nov 28;8:218. doi: 10.1186/1749-8090-8-218. J Cardiothorac Surg. 2013. PMID: 24286219 Free PMC article.
-
Curcumin- and Cyclopamine-Loaded Liposomes to Enhance Therapeutic Efficacy Against Hepatic Fibrosis.Drug Des Devel Ther. 2020 Dec 23;14:5667-5678. doi: 10.2147/DDDT.S287442. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 33380787 Free PMC article.
-
The Atrial Natriuretic Peptide-to-brain Natriuretic Peptide Ratio Predicts Left Atrial Reverse Remodeling after Rhythm Control Therapy in Patients with Persistent Atrial Fibrillation.Intern Med. 2023 Nov 15;62(22):3283-3290. doi: 10.2169/internalmedicine.1478-22. Epub 2023 Feb 22. Intern Med. 2023. PMID: 36823080 Free PMC article.
-
A critical role of AREG for bleomycin-induced skin fibrosis.Cell Biosci. 2021 Feb 23;11(1):40. doi: 10.1186/s13578-021-00553-0. Cell Biosci. 2021. PMID: 33622407 Free PMC article.
References
-
- Bando K, Kasegawa H, Okada Y, Kobayashi J, Kada A, Shimokawa T, Nasu M, Nakatani S, Niwaya K, Tagusari O. Impact of preoperative and postoperative atrial fibrillation on outcome after mitral valvuloplasty for nonischemic mitral regurgitation. J Thorac Cardiovasc Surg. 2005;129(5):1032–1040. doi: 10.1016/j.jtcvs.2004.10.037. - DOI - PubMed
-
- Prasad SM, Maniar HS, Camillo CJ, Schuessler RB, Boineau JP, Sundt TM 3rd, Cox JL, Damiano RJ Jr. The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures. J Thorac Cardiovasc Surg. 2003;126(6):1822–1828. doi: 10.1016/S0022-5223(03)01287-X. - DOI - PubMed
-
- Wellens F, Casselman F, Geelen P, Brugada P, Van Praet F, De Geest R, Degrieck I, Vanermen H. Combined atrial fibrillation and mitral valve surgery using radiofrequency technology. Semin Thorac Cardiovasc Surg. 2002;14(3):219–225. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials